In order to look for a second hit required for a strong activation of GLI1, we studied in depth the transcriptomic analysis performed in Bal et al.6, and unraveled an approximately 17-fold increased expression of ARHGAP36 mRNA in BDCS samples. The gene discussed is ARHGAP36; the disease is Bazex-Dupré-Christol syndrome.